01 OXALIPLATIN (2)
02 Oxaliplatin (2)
01 AqVida GmbH (2)
02 HOSPIRA WORLDWIDE (2)
01 INJECTABLE;INTRAVENOUS (2)
02 SOLUTION FOR INFUSION (2)
01 100MG/20ML (1)
02 100MG/20ML (5MG/ML) (1)
03 50MG/10ML (1)
04 50MG/10ML (5MG/ML) (1)
01 Germany (2)
02 USA (2)
19
AqVida GmbH, based in Germany, is a pharmaceutical company.
One of their notable products is Oxaliplatin, with a corresponding application number 78813 and regulatory information .
proudly manufactured in the
AqVida GmbH's SOLUTION FOR INFUSION, medication with 100MG/20ML of Oxaliplatin.
18
AqVida GmbH, based in Germany, is a pharmaceutical company.
One of their notable products is Oxaliplatin, with a corresponding application number 78813 and regulatory information .
proudly manufactured in the
AqVida GmbH's SOLUTION FOR INFUSION, medication with 50MG/10ML of Oxaliplatin.
17
Hospira, Inc., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is OXALIPLATIN, with a corresponding application number 78813 and regulatory information .
proudly manufactured in the
approval since 2009-08-07
Hospira, Inc.'s OXALIPLATIN INJECTABLE;INTRAVENOUS, medication with 100MG/20ML (5MG/ML) of OXALIPLATIN.
16
Hospira, Inc., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is OXALIPLATIN, with a corresponding application number 78813 and regulatory information .
proudly manufactured in the
approval since 2009-08-07
Hospira, Inc.'s OXALIPLATIN INJECTABLE;INTRAVENOUS, medication with 50MG/10ML (5MG/ML) of OXALIPLATIN.